1. Home
  2. OFG vs BEAM Comparison

OFG vs BEAM Comparison

Compare OFG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • BEAM
  • Stock Information
  • Founded
  • OFG 1964
  • BEAM 2017
  • Country
  • OFG United States
  • BEAM United States
  • Employees
  • OFG N/A
  • BEAM N/A
  • Industry
  • OFG Major Banks
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OFG Finance
  • BEAM Health Care
  • Exchange
  • OFG Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • OFG 1.9B
  • BEAM 1.6B
  • IPO Year
  • OFG N/A
  • BEAM 2020
  • Fundamental
  • Price
  • OFG $45.01
  • BEAM $20.01
  • Analyst Decision
  • OFG Buy
  • BEAM Strong Buy
  • Analyst Count
  • OFG 3
  • BEAM 11
  • Target Price
  • OFG $44.00
  • BEAM $48.90
  • AVG Volume (30 Days)
  • OFG 271.9K
  • BEAM 2.0M
  • Earning Date
  • OFG 07-17-2025
  • BEAM 08-05-2025
  • Dividend Yield
  • OFG 2.67%
  • BEAM N/A
  • EPS Growth
  • OFG 6.67
  • BEAM N/A
  • EPS
  • OFG 4.18
  • BEAM N/A
  • Revenue
  • OFG $623,009,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • OFG $2.30
  • BEAM N/A
  • Revenue Next Year
  • OFG $2.61
  • BEAM $8.82
  • P/E Ratio
  • OFG $10.76
  • BEAM N/A
  • Revenue Growth
  • OFG N/A
  • BEAM N/A
  • 52 Week Low
  • OFG $33.15
  • BEAM $13.53
  • 52 Week High
  • OFG $47.66
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • OFG 73.44
  • BEAM 68.31
  • Support Level
  • OFG $42.54
  • BEAM $16.59
  • Resistance Level
  • OFG $43.58
  • BEAM $17.38
  • Average True Range (ATR)
  • OFG 0.90
  • BEAM 1.10
  • MACD
  • OFG 0.31
  • BEAM 0.35
  • Stochastic Oscillator
  • OFG 95.19
  • BEAM 89.70

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: